866-997-4948(US-Canada Toll Free)

Global Prostate Cancer Drugs Market Size, Status and Forecast 2022

Published By :

QYResearch

Published Date : Mar 2017

Category :

Cancer

No. of Pages : 119 Pages


This report studies the global Prostate Cancer Drugs market, analyzes and researches the Prostate Cancer Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline
Merck Group
Novartis
Amgen
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Prostate Cancer Drugs can be split into
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy

Market segment by Application, Prostate Cancer Drugs can be split into
Clinics
Hospitals


Table of Contents

Global Prostate Cancer Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Prostate Cancer Drugs
1.1 Prostate Cancer Drugs Market Overview
1.1.1 Prostate Cancer Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Prostate Cancer Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Prostate Cancer Drugs Market by Type
1.3.1 Hormonal Therapy
1.3.2 Chemotherapy
1.3.3 Immunotherapy
1.3.4 Targeted Therapy
1.4 Prostate Cancer Drugs Market by End Users/Application
1.4.1 Clinics
1.4.2 Hospitals

2 Global Prostate Cancer Drugs Competition Analysis by Players
2.1 Prostate Cancer Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 AbbVie
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Astellas Pharma
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Astra Zeneca
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Johnson & Johnson
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Sanofi
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 GlaxoSmithKline
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Merck Group
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Novartis
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Amgen
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Bayer HealthCare
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Ferring Pharmaceutical
3.12 Janssen Pharmaceuticals
3.13 Endo Pharmaceuticals
3.14 BMS
3.15 Takeda Pharmaceuticals
3.16 Northwest Biotherapeutics
3.17 Teva Pharmaceutical
3.18 Boehringer Ingelheim
3.19 Foresee Pharmaceuticals
3.20 Tokai Pharmaceuticals
3.21 Spectrum Pharmaceuticals

4 Global Prostate Cancer Drugs Market Size by Type and Application (2012-2017)
4.1 Global Prostate Cancer Drugs Market Size by Type (2012-2017)
4.2 Global Prostate Cancer Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Prostate Cancer Drugs in Future
4.4 Top Consumer/End Users of Prostate Cancer Drugs

5 United States Prostate Cancer Drugs Development Status and Outlook
5.1 United States Prostate Cancer Drugs Market Size (2012-2017)
5.2 United States Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Prostate Cancer Drugs Development Status and Outlook
6.1 EU Prostate Cancer Drugs Market Size (2012-2017)
6.2 EU Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Prostate Cancer Drugs Development Status and Outlook
7.1 Japan Prostate Cancer Drugs Market Size (2012-2017)
7.2 Japan Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Prostate Cancer Drugs Development Status and Outlook
8.1 China Prostate Cancer Drugs Market Size (2012-2017)
8.2 China Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Prostate Cancer Drugs Development Status and Outlook
9.1 India Prostate Cancer Drugs Market Size (2012-2017)
9.2 India Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Prostate Cancer Drugs Development Status and Outlook
10.1 Southeast Asia Prostate Cancer Drugs Market Size (2012-2017)
10.2 Southeast Asia Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Prostate Cancer Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Prostate Cancer Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Prostate Cancer Drugs Market Size by Application (2017-2022)

12 Prostate Cancer Drugs Market Dynamics
12.1 Prostate Cancer Drugs Market Opportunities
12.2 Prostate Cancer Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Prostate Cancer Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Prostate Cancer Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Prostate Cancer Drugs Product Scope
Figure Global Prostate Cancer Drugs Market Size (Million USD) (2012-2017)
Table Global Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Prostate Cancer Drugs Market Share by Regions in 2016
Figure United States Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Prostate Cancer Drugs Market Share by Type in 2016
Figure Hormonal Therapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Chemotherapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Immunotherapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Targeted Therapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Prostate Cancer Drugs Market Share by Application in 2016
Figure Prostate Cancer Drugs Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Figure Prostate Cancer Drugs Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Figure Prostate Cancer Drugs Market Size (Million USD) and Growth Rate in Applications 3 (2012-2017)
Table Prostate Cancer Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016
Figure Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017
Table AbbVie Basic Information List
Table Prostate Cancer Drugs Business Revenue of AbbVie (2012-2017)
Figure AbbVie Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Astellas Pharma Basic Information List
Table Prostate Cancer Drugs Business Revenue of Astellas Pharma (2012-2017)
Figure Astellas Pharma Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Astra Zeneca Basic Information List
Table Prostate Cancer Drugs Business Revenue of Astra Zeneca (2012-2017)
Figure Astra Zeneca Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Prostate Cancer Drugs Business Revenue of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Prostate Cancer Drugs Business Revenue of Sanofi (2012-2017)
Figure Sanofi Prostate Cancer Drugs Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Prostate Cancer Drugs Business Revenue of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Merck Group Basic Information List
Table Prostate Cancer Drugs Business Revenue of Merck Group (2012-2017)
Figure Merck Group Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Prostate Cancer Drugs Business Revenue of Novartis (2012-2017)
Figure Novartis Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Prostate Cancer Drugs Business Revenue of Amgen (2012-2017)
Figure Amgen Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Bayer HealthCare Basic Information List
Table Prostate Cancer Drugs Business Revenue of Bayer HealthCare (2012-2017)
Figure Bayer HealthCare Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Ferring Pharmaceutical Basic Information List
Table Prostate Cancer Drugs Business Revenue of Ferring Pharmaceutical (2012-2017)
Figure Ferring Pharmaceutical Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Janssen Pharmaceuticals Basic Information List
Table Prostate Cancer Drugs Business Revenue of Janssen Pharmaceuticals (2012-2017)
Figure Janssen Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Endo Pharmaceuticals Basic Information List
Table Prostate Cancer Drugs Business Revenue of Endo Pharmaceuticals (2012-2017)
Figure Endo Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016
Table BMS Basic Information List
Table Prostate Cancer Drugs Business Revenue of BMS (2012-2017)
Figure BMS Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Takeda Pharmaceuticals Basic Information List
Table Prostate Cancer Drugs Business Revenue of Takeda Pharmaceuticals (2012-2017)
Figure Takeda Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Northwest Biotherapeutics Basic Information List
Table Prostate Cancer Drugs Business Revenue of Northwest Biotherapeutics (2012-2017)
Figure Northwest Biotherapeutics Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Teva Pharmaceutical Basic Information List
Table Prostate Cancer Drugs Business Revenue of Teva Pharmaceutical (2012-2017)
Figure Teva Pharmaceutical Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Prostate Cancer Drugs Business Revenue of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Foresee Pharmaceuticals Basic Information List
Table Prostate Cancer Drugs Business Revenue of Foresee Pharmaceuticals (2012-2017)
Figure Foresee Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Tokai Pharmaceuticals Basic Information List
Table Prostate Cancer Drugs Business Revenue of Tokai Pharmaceuticals (2012-2017)
Figure Tokai Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Spectrum Pharmaceuticals Basic Information List
Table Prostate Cancer Drugs Business Revenue of Spectrum Pharmaceuticals (2012-2017)
Figure Spectrum Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016
Table Global Prostate Cancer Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2012
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2013
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2014
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2015
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2016
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2017
Table Global Prostate Cancer Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2012
Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2013
Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2014
Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2015
Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2016
Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Prostate Cancer Drugs
Figure United States Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016
Figure United States Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017
Figure EU Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016
Figure EU Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017
Figure Japan Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016
Figure Japan Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017
Figure China Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016
Figure China Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017
Figure India Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016
Figure India Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017
Figure Southeast Asia Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016
Figure Southeast Asia Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017
Figure Global Prostate Cancer Drugs Market Size (Million USD) (Value) by Regions (2017-2022)
Table Global Prostate Cancer Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Regions in 2017
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Regions in 2022
Figure United States Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
Figure EU Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
Figure Japan Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
Figure China Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
Figure India Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)
Table Global Prostate Cancer Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2017
Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2022
Table Global Prostate Cancer Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2017
Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2022

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *